Signature for Precise Chemosensitivity Prediction in PDAC

Clinical trial NCT06461598 · COMPLETED

Trial details

NCT number: NCT06461598
Sponsor: Ruijin Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Pancreatic Cancer

Start date: 2018-01-01
Primary completion: 2020-03-16
Enrollment: 365

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.